Relative Bioavailability of Gantenerumab Produced by G4 Process Versus G3 Process Following Subcutaneous (SC) Injection in Healthy Participants
Clinical trial NCT03236844 · COMPLETED
Trial details
- NCT number
- NCT03236844
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2017-12-15
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.